metronomic chemotherapy
Showing 1 - 25 of >10,000
Gastric Cancer Trial in Shanghai (sintilimab+metronomic PLOF)
Recruiting
- Gastric Cancer
- sintilimab+metronomic PLOF
-
Shanghai, ChinaHuashan Hospital, Fudan University
Sep 22, 2023
Breast Cancer, Chemo Effect Trial in Beijing (Chidamide)
Recruiting
- Breast Cancer
- Chemotherapy Effect
-
Beijing, Beijing, ChinaNational Cancer Center/National Clinical Research Center for Can
Feb 17, 2023
Non Small Cell Lung Cancer (NSCLC), Malignant Pleural Mesothelioma (MPM) Trial in Marseille (Vinorelbine)
Completed
- Non Small Cell Lung Cancer (NSCLC)
- Malignant Pleural Mesothelioma (MPM)
-
Marseille, FranceAssistance Publique des Hôpitaux de Marseille (CEPCM)
Nov 15, 2022
Breast Cancer Trial in Zhengzhou (Capecitabine+endocrine therapy, Placebo+endocrine therapy)
Recruiting
- Breast Cancer
- Capecitabine+endocrine therapy
- Placebo+endocrine therapy
-
Zhengzhou, Henan, ChinaHenan cancer hospital
Nov 19, 2022
NSCLC, Carcinoma Breast Trial in Suzhou (Vinorelbine, Radiotherapy, PD-1/PD-L1 inhibitor)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Carcinoma Breast
- Vinorelbine
- +4 more
-
Suzhou, ChinaSecond Affiliated Hospital of Soochow University
Oct 29, 2022
Head and Neck Squamous Cell Carcinoma Trial in Guangzhou (Capecitabine)
Recruiting
- Head and Neck Squamous Cell Carcinoma
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Feb 15, 2022
Breast Cancer Trial in Guangzhou (Inetetamab Plus Cyclophosphamide Metronomic Chemotherapy Plus AI)
Recruiting
- Breast Cancer
- Inetetamab Plus Cyclophosphamide Metronomic Chemotherapy Plus AI
-
Guangzhou, Guangdong, ChinaShusen Wang
Jul 1, 2021
Neuroendocrine Tumors, Frailty, Chemo Effect Trial in Milan (Temozolomide capsule)
Recruiting
- Neuroendocrine Tumors
- +2 more
- Temozolomide capsule
-
Milan, ItalyEuropean Institute of Oncology, IEO, IRCCS
Sep 21, 2022
Breast Cancer Trial in Greenville (drug, procedure, radiation)
Terminated
- Breast Cancer
- Doxorubicin / Cyclophosphamide / Paclitaxel / Carboplatin
- +2 more
-
Greenville, North CarolinaBrody School of Medicine at East Carolina University
May 4, 2021
Colorectal Cancer Trial in Shanghai (Capecitabine)
Terminated
- Colorectal Cancer
-
Shanghai, ChinaDepartment of Oncology, Ruijin Hospital
Apr 28, 2021
Pancreatic Cancer Trial in Shanghai (Capecitabine)
Recruiting
- Pancreatic Cancer
-
Shanghai, ChinaDepartment of Oncology, Ruijin Hospital
Apr 29, 2021
Metastatic Colorectal Cancer Trial in France (other, procedure, drug)
Not yet recruiting
- Metastatic Colorectal Cancer
- quality of life questionnaires
- +6 more
-
Besançon, France
- +6 more
Jul 15, 2022
Solid Tumor, Osteosarcoma Trial in Bordeaux, Lille, Lyon (Sirolimus combined with CP, MT and ZA)
Recruiting
- Solid Tumor
- Osteosarcoma
- Sirolimus combined with CP, MT and ZA
-
Bordeaux, France
- +2 more
May 4, 2021
Breast Cancer Trial in Guangzhou (Capecitabine)
Completed
- Breast Cancer
-
Guangzhou, Guangdong, ChinaSun Yat-sen University, Cancer Center
May 22, 2020
Colo-rectal Cancer, Metastatic Cancer Trial in Besançon, Dijon, Montbéliard (Regorafenib, Cyclophosphamide, Capecitabine)
Active, not recruiting
- Colo-rectal Cancer
- Metastatic Cancer
- Regorafenib
- +3 more
-
Besançon, France
- +2 more
Jan 24, 2023
Breast Cancer Trial in Xi'an (metronomic oral vinorelbine plus anlotinib)
Recruiting
- Breast Cancer
- metronomic oral vinorelbine plus anlotinib
-
Xi'an, Shaanxi, ChinaXi'an International Medical Center Hospital
Aug 27, 2023
Breast Cancer Trial in Guangzhou (Capecitabine, Aromatase Inhibitor)
Active, not recruiting
- Breast Cancer
- Capecitabine
- Aromatase Inhibitor
-
Guangzhou, Guangdong, ChinaState Key Laboratory of Oncology in South China, Sun Yat-sen Uni
Jan 27, 2023
Advanced Breast Cancer Trial in Milan (Vinorelbine, Capecitabine, Cyclophosphamide)
Unknown status
- Advanced Breast Cancer
- Vinorelbine
- +2 more
-
Milan, ItalyEuropean Institute of Oncology
Apr 24, 2020